Tech Company Financing Transactions

IntelliCyt Funding Round

IntelliCyt secured a $5.2 million investment round on 6/11/2014. Investors included Oxford Finance.

Transaction Overview

Company Name
Announced On
6/11/2014
Transaction Type
Debt
Amount
$5,200,000
Round
Undisclosed
Investors

Oxford Finance (Christopher Herr)

Proceeds Purpose
The company intends to use the funds for working capital and to support its product development and marketing initiatives.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9620 San Mateo Boulevard Northeast
Albuquerque, NM 87113
USA
Email Address
Overview
IntelliCyt delivers tools and solutions to answer fundamental and complex biological questions through both suspension-cell-based and bead-based analyses.
Profile
IntelliCyt LinkedIn Company Profile
Social Media
IntelliCyt Company Twitter Account
Company News
IntelliCyt News
Facebook
IntelliCyt on Facebook
YouTube
IntelliCyt on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Terry Dunlay
  Terry Dunlay LinkedIn Profile  Terry Dunlay Twitter Account  Terry Dunlay News  Terry Dunlay on Facebook
Chief Financial Officer
Dennis Hynson
  Dennis Hynson LinkedIn Profile  Dennis Hynson Twitter Account  Dennis Hynson News  Dennis Hynson on Facebook
Chief Technical Officer
Thomas Duensing
  Thomas Duensing LinkedIn Profile  Thomas Duensing Twitter Account  Thomas Duensing News  Thomas Duensing on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/11/2014: Core Informatics venture capital transaction
Next: 6/11/2014: Gill Business Systems venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary